SEC Form 4/A · accession 0000899243-16-011405
KERYX BIOPHARMACEUTICALS INC · KERX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Brian Adams
Officer — VP and General Counsel
Period of report
Jan 5, 2016
Accepted (ET)
Jan 8, 2016 · 5:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001114220
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Jan 5, 2016 | S | 3,003 | $4.83 | D | 54,455 | D | |
| Common StockF1,F2,F3 | Jan 6, 2016 | S | 1 | $4.70 | D | 54,454 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale of a total of 3,004 shares of common stock was made in order to satisfy Mr. Adams' income tax withholding obligation upon the vesting of 7,959 shares of restricted stock on January 4, 2016. Mr. Adams had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- F2The Form 4 originally filed on January 6, 2016 is being amended to revise Column 2 and Column 4 to state that (a) 3,003 shares of common stock were disposed of on January 5, 2016 at $4.83 per share and (b) 1 share of common stock was disposed of on January 6, 2016 at $4.70 per share.
- F3Includes 35,914 shares of restricted stock.